Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05971823 · ClinicalTrials.gov registry record · NA
Effects of Electronic Cigarette Flavors on Abuse Liability in Smokers (P3-Taste)
A NA study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT05971823 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 32 participants.
The verdict
NCT05971823, a NA study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if abuse liability indices will be impacted by varying flavors and e-cigarette (ECIG) nicotine delivery capability (i.e., nicotine flux) among current combustible cigarette users. The investigators will compare abuse liability indices between three FDA-authorized ECIG products that vary in nicotine flux (but are all tobacco flavor) and own brand cigarettes. The investigators will also test the influence of ECIG flavor availability (tobacco vs. menthol) within three ECIG product classes.
Interventions
- OTHER Tobacco product administration and assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2023-07-31 |
| Est. Completion | 2024-07-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05971823
The ClinicalTrials.gov registry entry for NCT05971823 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tobacco product administration and assessment is the first listed.
NCT05971823 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05971823 about?
NCT05971823 is a clinical study titled "Effects of Electronic Cigarette Flavors on Abuse Liability in Smokers (P3-Taste)". The purpose of this study is to determine if abuse liability indices will be impacted by varying flavors and e-cigarette (ECIG) nicotine delivery capability (i.e., nicotine flux) among current combustible cigarette users. The investigators will compare abuse liability indices between three FDA-auth...
What is the current status of trial NCT05971823?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2023-07-31. Estimated completion is 2024-07-26.
What interventions are being tested in trial NCT05971823?
The interventions under investigation include: Tobacco product administration and assessment (OTHER).
Who is sponsoring clinical trial NCT05971823?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.